
US electric car manufacturer Tesla is aiming to increase in production at its factory in Grünheide near Berlin in 2026, despite the difficult market situation in Germany.
Output already grew in each quarter of the past year as planned, plant manager André Thierig told dpa in a recent interview.
"We are therefore looking forward to the new year with optimism and expect a further increase," he said, describing the current situation as "stable."
According to the company, around 11,000 employees at what it calls a Gigafactory in the state of Brandenburg produce some 5,000 vehicles per week, which equates to around 250,000 vehicles per year.
"We were able to secure jobs here and were never affected by production stoppages or job cuts like other industrial sites in Germany," said Thierig.
The site was expanded in 2025 with substantial investments not only in the launch of the models but including the construction of a new building for pre-series vehicles.
Canada has also been added as a market, he said, allowing customers in that country to purchase vehicles from Grünheide at a lower price because they are not subject to the higher US import duties.
Sector navigating global challenge
The automotive industry is in a global profitability crisis. In Germany, the electric car market has picked up again, but it remains difficult for Tesla: from January to November 2025, 17,358 new Tesla cars were registered, according to the Federal Motor Transport Authority, a decrease of around 48% compared to the same period last year.
latest_posts
- 1
The most effective method to Pick the Right Material Organization: Your Definitive Aide - 2
Step by step instructions to Get the Best Vehicle Rent Arrangement: Insider Tips and Systems - 3
More people are addicted to marijuana, but fewer of them are seeking help, experts say - 4
A Manual for SUVs with Less Noteworthy Gas Mileage - 5
Figure out How to Acquire Rewarding Open Record Rewards
4 Must-Visit bar-b-que Eateries This Year
Top 10 Arising Advances That Will Shape What's in store
How a rare drug made from scientists' blood saves babies from botulism
Top 5 Top of the line Books of the Year
Figure out How to Augment the Advantages of a Web-based Degree
Report in relation to renaming Herzog Park set to be withdrawn
Lilly becomes first healthcare firm to join trillion-dollar club, Wall Street reacts
Baby takes 1st steps after receiving groundbreaking gene-edited therapy
21 Incredibly Entertaining Contemplations To Observe Consistently













